The Weekly Brief
Global Market Insights Strategy Team
Thought of the week
Of the major developed economies, the UK has made the most impressive start in vaccinating its population. Its government has set an ambitious target to offer a first vaccine dose to all those over the age of 70 along with frontline workers and the clinically vulnerable, by mid-February – a target it looks set to meet. The US and in particular the major eurozone economies have got off to slower starts. Our base case though, is that vaccine rollouts allow for developed economies to begin recovering in the spring, and that activity accelerates sharply in the second half of the year as consumers spend their accumulated savings from the pandemic. While there are plenty of reasons to be optimistic, investors should remain watchful of information around virus mutations and the potential implications for vaccine efficacy that could delay this timetable.
The UK is leading the race to vaccinate its population
Cumulative Covid-19 vaccine doses administered per 100 people
This document is a general communication being provided for informational purposes only. It is educational in nature and not designed to be taken as advice or a recommendation for any specific investment product, strategy, plan feature or other purpose in any jurisdiction, nor is it a commitment from J.P. Morgan Asset Management or any of its subsidiaries to participate in any of the transactions mentioned herein. Any examples used are generic, hypothetical and for illustration purposes only. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit, and accounting implications and determine, together with their own professional advisers, if any investment mentioned herein is believed to be suitable to their personal goals. Investors should ensure that they obtain all available relevant information before making any investment. Any forecasts, figures, opinions or investment techniques and strategies set out are for information purposes only, based on certain assumptions and current market conditions and are subject to change without prior notice. All information presented herein is considered to be accurate at the time of production, but no warranty of accuracy is given and no liability in respect of any error or omission is accepted. It should be noted that investment involves risks, the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested. Both past performance and yields are not a reliable indicator of current and future results.
This communication is issued in the UK by JPMorgan Asset Management (UK) Limited, which is authorised and regulated by the Financial Conduct Authority. Registered in England No. 01161446. Registered address: 25 Bank Street, Canary Wharf, London E14 5JP.